Investigating the Effect of Obicetrapib on Lipoprotein Metabolism
Clinical trial NCT05972278 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05972278
- Sponsor
- NewAmsterdam Pharma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2024-09-26
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.